title: Back to the future: learning from cancer vaccine trials in Cardiff.
abstract: The early 1990s saw the first clinical testing of several therapeutic cancer vaccines. There was great optimism that these vaccines could be used as an alternative therapy for patients who had failed to respond to conventional cancer therapies. This article provides a personal perspective on the cancer vaccine field after being involved with a series of clinical trials in the United Kingdom (Cardiff) starting in the mid 1990s. It will also review the developments in technology and improved knowledge of the immune system that have informed the design of a new generation of cancer vaccine trials that will start in Cardiff in 2012.
authors: Institute of Cancer and Genetics, Cardiff University School of Medicine, Cardiff, UK. mans@cf.ac.uk
authors: Stephen
authors: S
authors: Man
mesh_terms: D019264:Adoptive Transfer; D019496:Cancer Vaccines / Q000276:immunology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic / Q000639:trends; D005260:Female; D052162:Human papillomavirus 16 / Q000235:genetics / Q000276:immunology; D052161:Human papillomavirus 18 / Q000235:genetics / Q000276:immunology; D006801:Humans; D009856:Oncogene Proteins, Viral / Q000235:genetics / Q000276:immunology; D030361:Papillomavirus Infections / Q000276:immunology / Q000473:pathology / Q000517:prevention & control*; D013601:T-Lymphocytes / Q000276:immunology* / Q000637:transplantation; D006113:United Kingdom; D002583:Uterine Cervical Neoplasms / Q000276:immunology / Q000473:pathology / Q000517:prevention & control*; D014614:Vaccines, Synthetic
chemical_list: D019496:Cancer Vaccines; D009856:Oncogene Proteins, Viral; D014614:Vaccines, Synthetic